NCT07592403 Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis
| NCT ID | NCT07592403 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beni-Suef University |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-05-16 |
| Primary Completion | 2027-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-05-16 with a primary completion date of 2027-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, sham-controlled, double-blinded clinical trial aims to investigate the effects of pulsed electromagnetic field therapy (PEMF) on pain intensity, quality of life, and pelvic floor morphometric changes assessed by four-dimensional trans perineal ultrasound (4D TPUS) in women diagnosed with endometriosis. Participants will be randomly allocated into either a PEMF therapy group or a sham PEMF control group. Both groups will continue receiving stable standard medical care throughout the study period. Assessments will be conducted at baseline, after completion of the 8-week intervention period, and at 3-month follow-up.
Eligibility Criteria
Inclusion Criteria: 1. Women aged 18 to 45 years 2. Clinically, radiologically, or laparoscopically diagnosed endometriosis 3. Chronic pelvic pain persisting for at least 6 months 4. Stable pharmacological or hormonal treatment for at least 3 months before enrollment 5. Ability to understand study procedures and provide written informed consent Exclusion Criteria: 1. Pregnancy or planned pregnancy during the study period 2. History of gynecological or pelvic malignancy 3. Active pelvic inflammatory disease or acute pelvic infection 4. Implanted electronic medical devices such as pacemakers or neurostimulators 5. Previous pelvic surgery within the past 6 months 6. Participation in another clinical trial during the previous 3 months 7. Neurological, rheumatological, or severe musculoskeletal disorders affecting assessment procedures 8. Contraindications to electromagnetic therapy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07592403 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07592403 currently recruiting?
Yes, NCT07592403 is actively recruiting participants. Contact the research team at Marwa.elsayed@pt.bsu.edu.eg for enrollment information.
Where is the NCT07592403 trial being conducted?
This trial is being conducted at Banī Suwayf, Egypt.
Who is sponsoring the NCT07592403 clinical trial?
NCT07592403 is sponsored by Beni-Suef University. The trial plans to enroll 60 participants.